{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:38:34Z","timestamp":1790390314368,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.antiviral.2005.06.002","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T17:57:50Z","timestamp":1122659870000},"page":"49-55","source":"Crossref","is-referenced-by-count":32,"title":["Broad-spectrum inhibitor of viruses in the Flaviviridae family"],"prefix":"10.1016","volume":"68","author":[{"given":"Joshua O.","family":"Ojwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoukath","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Smee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Morrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Shimasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Sidwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2005.06.002_bib1","first-page":"1681","article-title":"To C or not to C: these are the questions","volume":"85","author":"Alter","year":"1995","journal-title":"J. Am. Soc. Hematol."},{"key":"10.1016\/j.antiviral.2005.06.002_bib2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States","volume":"327","author":"Alter","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2005.06.002_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.1840210306","article-title":"Persistent hepatitis C viremia after acute self-limiting postransfusion hepatitis C","volume":"21","author":"Barrera","year":"1995","journal-title":"Hepatology"},{"issue":"5498","key":"10.1016\/j.antiviral.2005.06.002_bib4","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2005.06.002_bib5","first-page":"845","article-title":"1999 Outbreak of West Nile-like viral encephalitis-New York","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2005.06.002_bib6","first-page":"617","article-title":"West Nile virus activity-eastern United States, 2001","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2005.06.002_bib7","first-page":"497","article-title":"West Nile activity-United States 2001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2005.06.002_bib8","first-page":"645","article-title":"West Nile activity-United States 2001","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2005.06.002_bib9","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.antiviral.2005.06.002_bib10","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3201\/eid0812.020532","article-title":"First isolation of West Nile virus from patient with encephalitis in the United States","volume":"8","author":"Huang","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2005.06.002_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/jm00207a009","article-title":"Imidazo[1,2-a]-s-triazine nucleosides. Synthesis and antiviral activity of N-bridgedhead guanine, guanosine, and guanosine monophosphate analogues of imidazo[1,2-a]-s-triazine","volume":"21","author":"Kim","year":"1978","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2005.06.002_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.44.4.859-866.2000","article-title":"Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497\u2014a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon","volume":"44","author":"Markland","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2005.06.002_bib13","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1073\/pnas.91.7.2395","article-title":"Dengue: the risk to developed and developing countries","volume":"91","author":"Monath","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2005.06.002_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0166-3542(02)00013-X","article-title":"Identification of active compounds against a New York isolate of West Nile virus","volume":"55","author":"Morey","year":"2002","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.06.002_bib15","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1002\/hep.510260701","article-title":"National Institutes of Health Consensus development conference panel statement: management of hepatitis C","volume":"26","author":"National Institutes of Health","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2005.06.002_bib16","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.4049\/jimmunol.160.7.3487","article-title":"Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulate fg12 prothrombinase and preserves the Thi cytokines production but inhibits Th2 cytokines response","volume":"160","author":"Ning","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2005.06.002_bib17","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.1073\/pnas.95.15.8874","article-title":"Potent inhibition of respiratory syncitial virus replication using a 2-5 A-antisense chimera targeted to signals within the virus genomic RNA","volume":"95","author":"Player","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2005.06.002_bib18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/infdis\/167.6.1296","article-title":"Patterns of prevalence of hepatitis C virus infection in posttranfusion non-A, non-B hepatitis","volume":"167","author":"Prince","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2005.06.002_bib19","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alfa-2b plus ribavirin for 48 weeks or 24 week versus interferon alfa-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2005.06.002_bib20","first-page":"493","article-title":"A simple method of estimating fifty percent end points","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2005.06.002_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0166-3542(88)90044-7","article-title":"Antiviral activity and mode of action of ribavirin 5\u2032-sulfamate against Semliki Forest virus","volume":"10","author":"Smee","year":"1988","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.06.002_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0166-3542(92)90035-4","article-title":"Selective inhibition of arthropod-borne and arenavirus in vitro by 3\u2032-fluoro-3\u2032-deoxyadenosine","volume":"18","author":"Smee","year":"1992","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2005.06.002_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/AAC.22.3.499","article-title":"Effect of combinations of acyclovir with vidarabine or its 5\u2032-monophosphate on herpes simplex viruses in cell culture and in mice","volume":"22","author":"Schinazi","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2005.06.002_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C virus infections among injection drug users","volume":"74","author":"Thomas","year":"1995","journal-title":"Medicine"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354205001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354205001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T21:55:51Z","timestamp":1683150951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354205001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0166354205001191"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2005.06.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}